Burrill & Co commits funds to Minnesota life science industry
This article was originally published in Scrip
Executive Summary
Burrill & Co is to back the development of Minnesota's life science industry in a joint financial commitment reportedly worth nearly $1 billion. Burrill will team up with the property developer Tower Investments to attract biotech and biomedical businesses to the area.